- Ownership
- Activity
BLACR Stock Ownership Activity
BELLEVUE LIFE SCIENCES-RTS 13F holders
No value investing guru has made any change to the BELLEVUE LIFE SCIENCES-RTS (BLACR) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying BLACR now?
According to the latest SEC filing(s) BELLEVUE LIFE SCIENCES-RTS (BLACR) has not been purchased by any super investor.
To see more about who is investing in BELLEVUE LIFE SCIENCES-RTS (BLACR), please go to the BLACR ownership page.
2023 Q2
(1 result)
Reported price*: $0.17
2023 Q1
(1 result)
Reported price*: $0.17
2 of 2
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.